IRTC (iRhythm Technologies, Inc.) Stock Financials & Earnings

IRTCiRhythm Technologies, Inc.

Mkt Cap$4B

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$747M

Net Income (TTM)-$45M

EPS (TTM)-$1.41

Free Cash Flow (TTM)$35M

Gross Margin70.6%

Op. Margin-6.8%

Net Margin-6.0%

FCF Margin4.6%

P/S Ratio (TTM)5.3x

P/E Ratio (TTM)—

YoY Rev Growth+26.2%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$111M	$76M	-$40M
Q2 23	$124M	$86M	-$19M
Q3 23	$125M	$82M	-$28M
Q4 23	$133M	$87M	-$39M
Q1 24	$132M	$88M	-$38M
Q2 24	$148M	$103M	-$23M
Q3 24	$148M	$101M	-$50M
Q4 24	$164M	$115M	-$4M
Q1 25	$159M	$109M	-$33M
Q2 25	$187M	$133M	-$19M
Q3 25	$193M	$137M	-$8M
Q4 25	$209M	$148M	$9M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Quarter	Centers For Medicare And Medicaid	Commercial Payors	Healthcare Institutions	Non-Contracted Third-Party Payors
Q1 23	$26M	$62M	$16M	$7M
Q2 23	$31M	$67M	$18M	$8M
Q3 23	$31M	$67M	$18M	$8M
Q1 24	$32M	$72M	$20M	$9M
Q2 24	$36M	$79M	$22M	$10M
Q3 24	$36M	$77M	$23M	$11M
Q1 25	$38M	$84M	$27M	$10M
Q2 25	$44M	$98M	$32M	$13M
Q3 25	$48M	$99M	$33M	$14M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$53M	$124M	$176M
Q2 23	$62M	$103M	$165M
Q3 23	$47M	$111M	$158M
Q4 23	$36M	$98M	$134M
Q1 24	$520M	$49M	$569M
Q2 24	$551M	$11M	$561M
Q3 24	$520M	$2M	$522M
Q4 24	$420M	$116M	$536M
Q1 25	$375M	$145M	$521M
Q2 25	$309M	$236M	$546M
Q3 25	$256M	$310M	$565M
Q4 25	$236M	$348M	$584M

Shares Outstanding

Revenue Per Employee

Revenue / Employee